About one in every five people carries a version of a gene that, although largely unsung, appears to confer protection against both Alzheimer’s disease and Parkinson’s disease, Stanford Medicine investigators and their colleagues have learned.
Pfizer says IRA impact will be ‘modest,’ maps out R&D priority changes
Despite being an early critic of the Inflation Reduction Act, Pfizer told investors on Monday that the legislation is likely to have a “modest” impact
March 6, 2024